Temporal course of depressive symptoms during the development of Alzheimer disease

Neurology

Volumn 75, Issue 1, 2010, Pages 21-26

  Wilson, R S ^a,c   Hoganson, G M ^a   Rajan, K B ^b,c   Barnes, L L ^a,c   Mendes De Leon, C F ^b,c   Evans, D A ^b,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SELF REPORT;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; COHORT STUDIES; DEPRESSION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; LONGITUDINAL STUDIES; MALE; TIME FACTORS;

EID: 77954637784     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e620c5     Document Type: Article

References (40)

1. Berger AK, Fratiglioni L, Forsell Y, Winbald B, Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002.
2. Devanand DP, Sano M, Tang MX, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175- 182.
3. Gatz JL, Tyas SL, St. John P, Montgomery P. Do depressive symptoms predict Alzheimer's disease and dementia? J Gerontol A Biol Sci Med Sci 2005;60:744-747.
4. Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290-1293.
5. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364-370.
6. Wilson RS, Krueger KR, Arnold SE, et al. Loneliness and risk of Alzheimer's disease. Arch Gen Psychiatry 2007;64: 234-240.
7. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment. Arch Gen Psychiatry 2006;63:273-280.
8. Geda YE, Knopman DS, Mrazek DA, et al. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006;63:435-440.
9. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA. Chronic distress and incidence of mild cognitive impairment. Neurology 2007;68:2085-2092.
10. Lyketsos CG, Lopez O, Jones C, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475-1483.
11. Geda YE, Roberts RO, Knopman DS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging. Arch Gen Psychiatry 2008;65: 1193-1198.
12. Wilson RS, Arnold SE, Beck TL, Bienias JL, Bennett DA. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry 2008;65: 439-446.
13. Amieva H, Goff ML, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008;64:492-498.
14. Gilley DW, Wilson RS, Fleischman DA, Harrison DW, Goetz CG, Tanner CM. Impact of Alzheimer's-type dementia and information source on the assessment of depression. Psychol Assessment 1995;7:42-48.
15. Wilson RS, Aggarwal NT, Barnes LL, Bienias JL, Mendes de Leon CF, Evans DA. Biracial population study of mortality in mild cognitive impairment and AD. Arch Neurol 2009;66:767-772.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-944.
17. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
18. Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA. Mild cognitive impairment: risk of Alzheimer's disease and rate of cognitive decline. Neurology 2006;67:441-445.
19. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer's disease pathology and cerebral infarctions. Neurology 2005;64:834-841.
20. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D depression symptoms index. J Aging Health 1993;5:179-193.
21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
22. Wilson RS, Mendes de Leon CF, Bennett DA, Bienias JL, Evans DA. Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry 2004;75:126-129.
23. Wilson RS, Bienias JL, Mendes de Leon CF, Evans DA, Bennett DA. Negative affect and mortality in older persons. Am J Epidemiol 2003;158:827-835.
24. Shafer AB. Meta-analysis of the factor structures of 4 depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006;62:123-146.
25. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1989; 45:742-747.
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
27. Zegar SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-1060.
28. Davey A, Halverson CF, Zonderman A, Costa PT Jr. Change in depressive symptoms in the Baltimore Longitudinal Study of Aging. J Gerontol B Psychol Sci Soc Sci 2004;59:P270-P277.
29. Barefoot JC, Mortensen EL, Helms MJ, Avlund K, Schroll M. A longitudinal study of gender differences in depressive symptoms from age 50 to 80. Psychol Aging 2001;16: 342-345.
30. Holtzer R, Scarmeas N, Wegesin DJ, et al. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. J Am Geriatr Soc 2005;53:2083-2089.
31. Li YS, Meyer JS, Thornby J. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. Int J Geriatr Psychiatry 2001;16:718-727. (Pubitemid 32754933)
32. Butters MA, Klunk WE, Mathis CA, et al. Imaging Alzheimer's pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 2008; 22:261-268.
33. Rapp MA, Schnaider-Beeri M, Grossman HT, et al. Increased hippocampal plaques and tangles in patients with Alzheimer's disease with a lifetime history of major depression. Arch Gen Psychiatry 2006;63:161-167.
34. Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M. Increased neurofibrillary tangles in patients with Alzheimer's disease with comorbid depression. Am J Geriatr Psychiatry 2008;16:168-174.
35. Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 2003;61:1102-1107.
36. Wilson RS, Arnold SE, Schneider JA, Li Y, Bennett DA. Chronic distress, age-related neuropathology, and late life dementia. Psychosom Med 2007;69:47-53.
37. Butters MA, Young JB, Lopez O, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008;10:345-357.
38. Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry 1997;154: 562-565.
39. Soetanto A, Wilson RS, Talbot K, et al. Anxiety and depression are associated with microtubule-associated protein 2 and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry 2010;67:448-457.
40. Magarinos AM, McEwan BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 1995;69:83-88.